Projects

Evaluation of the in-vitro susceptibility for Plazomicin among Carbapenem resistant Enterobacterales isolates in a Tertiary care hospital

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - Ongoing

Project Lead

Ms. Jehosheba Persis M

Authors

Ms. Jehosheba Persis M, Dr. Priyadarshini A Padaki, Dr. Sneha May Kurian

Project Status

ongoing

Project Type

Diagnostic/Validational study